Devender Roberts

• Consultant in Maternal and Fetal Medicine, Liverpool
• Women? Hospital, Crown Street, Liverpool

A prospective study with long-term follow-up including range-of-motion measurements erectile dysfunction organic causes order viagra sublingual no prescription. Competence levels in musculoskeletal medicine: comparison of osteopathic and allopathic medical graduates erectile dysfunction statistics buy 100 mg viagra sublingual with amex. Prevalence of the rotator cuff tear increases with weakness in hemiplegic shoulder impotence by smoking viagra sublingual 100 mg buy without prescription. Risk factors for incidence of rotator cuff syndrome in a large working population reasons erectile dysfunction young age trusted 100 mg viagra sublingual. Which physical examination tests provide clinicians with the most value when examining the shoulder Comparison of ultrasonographic erectile dysfunction shots viagra sublingual 100 mg buy on-line, magnetic resonance imaging, and arthroscopic findings in seventy-one consecutive cases. Subacromial impingement syndrome­ effectiveness of physiotherapy and manual therapy. Blind or ultrasound-guided corticosteroid injections and short-term response in subacromial impingement syndrome: A randomized, doubleblind, prospective study. Histomorphologic changes of the long head of the biceps tendon in common shoulder pathologies. Association of biceps tendon tears with rotator cuff abnormalities: Degree of correlation with tears of the anterior and superior portions of the rotator cuff. Accuracy of palpating the long head of the biceps tendon: An ultrasonographic study. Non-operative treatment regime including eccentric training for lateral humeral epicondylalgia. Chronic lateral epicondylitis: Comparative effectiveness of a home exercise program including stretching alone versus stretching supplemented with eccentric or concentric strengthening. Comparative effectiveness of injection therapies in lateral epicondylitis: A systematic review and network meta-analysis of randomized controlled trials. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: A randomized controlled trial. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: A randomized, double-blind, placebo-controlled trial. Prevalence of tenosynovitis and other injuries of the upper extremities in repetitive work. Systematic review and metaanalysis on the work-related cause of de Quervain tenosynovitis: A critical appraisal of its recognition as an occupational disease. Mardani-Kivi M, Karimi Mobarakeh M, Bahrami F, HashemiMotlagh K, Saheb-Ekhtiari K, Akhoondzadeh N. Corticosteroid injection with or without thumb spica cast for de quervain tenosynovitis. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Osteoarthritis of the thumb carpometacarpal joint in women and occupational risk factors: A case-control study. Hypermobility associated with osteoarthritis of the thumb base: A clinical and radiological subset of hand osteoarthritis. Radiographic hand osteoarthritis: Incidence, patterns, and influence of preexisting disease in a population based sample. Diagnostic value of clinical grind test for carpometacarpal osteoarthritis of the thumb. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Comparison of two carpometacarpal stabilizing splints for individuals with thumb osteoarthritis. Comparison of custom-made and prefabricated neoprene splinting in patients with the first carpometacarpal joint osteoarthritis. Splinting for osteoarthritis of the carpometacarpal joint: A review of the evidence. Surgical treatment of trapeziometacarpal joint arthritis: A historical perspective. Total joint arthroplasty in the treatment of advanced stages of thumb carpometacarpal joint osteoarthritis. Rehabilitation protocol after suspension arthroplasty of thumb carpometacarpal joint osteoarthritis. The burden of hip osteoarthritis in the United States: Epidemiologic and economic considerations. Does ultrasound correlate with surgical or histologic findings in greater trochanteric pain syndrome Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. Greater trochanter bursitis pain syndrome in females with chronic low back pain and sciatica. Greater trochanteric pain syndrome, another cause of hip or thigh pain in multiple sclerosis. Greater trochanteric pain syndrome negatively affects work, physical activity and quality of life: A case control study. Ultrasound-guided corticosteroid injections for treatment of greater trochanteric pain syndrome: Greater trochanter bursa versus subgluteus medius bursa. Corticosteroid injections for greater trochanteric pain syndrome: A randomized controlled trial in primary care. Risk factors for pes anserinus tendinitis/ bursitis syndrome: A case control study. A prospective study of overuse knee injuries among female athletes with muscle imbalances and structural abnormalities. Relationship between tightness of the posterior muscles of the lower limb and plantar fasciitis. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: Influences of age, gender and osteoarthritis affecting other joints. Association between occupation and knee and hip replacement due to osteoarthritis: A case-control study. Evaluation of ultrasound-guided diagnostic local anaesthetic hip joint injection for osteoarthritis. Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: A long-term follow-up of a randomised trial. Steroid injection for osteoarthritis of the hip: A randomized, double-blind, placebo-controlled trial. Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndrome. Diagnostic imaging for chronic plantar heel pain: A systematic review and meta-analysis. Plantar fascia-specific stretching exercise improves outcomes in patients with chronic plantar fasciitis. Does the use of orthoses improve self-reported pain and function measures in patients with plantar fasciitis Treatment of plantar fasciitis by LowDye taping and iontophoresis: Short term results of a double blinded, randomised, placebo controlled clinical trial of dexamethasone and acetic acid. Ultrasound guided corticosteroid injection for plantar fasciitis: Randomised controlled trial. Short-term benefits of ultrasound-guided corticosteroid injection in plantar fasciitis. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. Use of platelet rich plasma to treat plantar fasciitis: Design of a multi centre randomized controlled trial. Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: A randomized controlled trial. Effectiveness of extracorporeal shock wave therapy in chronic plantar fasciitis: A meta-analysis. A systematic review of shockwave therapies in soft tissue conditions: Focusing on the evidence. Symptoms may fluctuate in severity from day to day but, in general, change only slowly with time. Apart from pain, functional impairment is an important problem that may result in participation restriction and reduced quality of life. These often use algorithms to allow classification based on different combinations of features which may include simple demographics. The weighting of various aspects within an individual is variable, and use of imaging and other investigations are not usually required (see Chapter 15). Pathologically it is usually characterized by exuberant new bone formation (most evident as osteophyte) and bone remodelling, synovial hyperplasia, and capsular thickening (see Chapter 3). Once the process is initiated, all the tissues in the joint are involved in what may be considered an adaptive response [12,24,25]. The increased metabolic activity by cartilage, new bone formation, and remodelling of the joint may help keep pace with tissue loss and redistribute mechanical forces across the compromised diverse insults outcome joint. The site of primary insult may be any tissue in the joint (bone, cartilage, synovium, capsule, ligament, muscle), because all are essential to its health and integrity. Caveats to defining subsets, however, include the lack of clear distinction between many subsets. It is often difficult, however, to disentangle deleterious initiating factors from events linked to tissue response, especially when studying established, particularly end-stage, disease. Physical and biomechanical factors, though usefully separated in test systems, are likely to be inexorably linked and interdependent in vivo. For example, we know that a certain amount of regular loading is required for the health of both cartilage and bone, and that either too little or too much loading may result in cartilage fibrillation and thinning [26]. The lateral radiograph on the left shows florid femoral osteophyte formation anteriorly and posteriorly as well as superior and inferior patellar and tibial osteophyte, whereas the only definite osteophyte seen in the knee on the right is a small superior patellar osteophyte. Common target sites are shown on the left in black (moderately common sites in older age shown in grey), whereas relatively spared sites of involvement are shown on the right in blue. Joints that have undergone major changes in orientation and function, to permit our bipedal gait and associated liberation of the upper limb, may not yet have adapted to their new functional requirements: they may be under-designed (that is, have poor functional reserve), and, therefore, more frequently require a reparative response in the face of insult. Within individual joints, there is additional specificity with respect to sites of maximal cartilage loss. For large joints, this most commonly occurs at sites of maximum load bearing, supporting the importance of physical factors. The mechanism underlying these striking age associations may relate to age-related decline in muscle function, impaired joint proprioception, reduction of vascular supply and nutrition of joint tissues, or reduced regenerative potential of connective tissue. There is a dramatic decline with ageing in the biomechanical properties of cartilage matrix [41], probably caused by subtle but cumulative changes in the structure of collagens, proteoglycans, and matrix proteins. The association between crystals and osteoarthritis In contrast to immature cartilage involved in endochondral ossification during growth, normal mature cartilage does not readily form calcium crystals within its matrix. In many tissues, including cartilage, the normal balance between tissue inhibitors and promotors of crystallization favours inhibition and this prevents inappropriate crystal formation despite the tissue having many components in solution at a concentration above their saturation point. Metabolically active hypertrophic chondrocytes, adjacent vascularity, and tendency to readily calcify cartilage are all features of endochondral ossification which is required as our skeleton is growing. In normal adult articular cartilage, chondrocytes become less active and lose the hypertrophic phenotype, vascularity recedes, matrix epitopes take on adult characteristics, and cartilage becomes resistant to crystal formation. It is for these reasons that crystal arthropathies are given greater prominence in this third edition of the textbook which previously was entitled Osteoarthritis. The discharging tophus in her little finger led to her presentation and diagnosis of gout. Osteoarthritis: a review of the cell biology involved and evidence for reversibility. Modulation of native chondroitin sulphate structure in tissue development and in disease. Osteoarthrosis: prevalence in the population and relationship between symptoms and X-ray changes. Osteoarthritis and articular cartilage use, disuse and abuse: experimental studies. Milwaukee shoulder syndrome: eleven additional cases with involvement of the knee in seven basic calcium phosphate deposition. Clinical and radiographic distribution of structural damage in erosive and nonerosive hand osteoarthritis. Erosive osteoarthritis: a more severe form of radiographic hand osteoarthritis rather than a distinct entity Association of radiographic hand osteoarthritis with radiographic knee osteoarthritis after meniscectomy. Age-related changes in the tensile properties of human articular cartilage: a comparative study between the femoral head of the hip joint and the talus of the ankle joint. Articular cartilage calcification in osteoarthritis-insights into crystal-induced stress. Promotion of articular cartilage matrix vesicle mineralization by type I collagen. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles. Comorbidities in patients with gout prior to and following diagnosis: case control study. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Ruffer was a pathologist in Cairo whose interest was aroused by the study of the extensive collection of mummies and other human remains which were being discovered with great frequency during this period. Palaeopathological evidence is, of course, not restricted to the study of mummified human remains although, because of soft tissue preservation, they are ideal. Paintings, drawings, sculpture, literature, and early medical texts can all be used as evidence for the presence and identification of early disease. The most widespread, common, and direct type of evidence however, particularly for disorders that affect the skeleton, is that derived from the study of human skeletal remains from archaeological sites. Apart from the interest in the occurrence of particular diseases at different time periods, palaeopathology can provide invaluable evidence for the frequency, distribution, and variation of expression of individual pathologies through time [3].

Syndromes

• Allergies to plants and other substances
• TIBC: 240-450 mcg/dL
• Your doctor may want to do blood and urine tests to help determine the proper prevention steps.
• Smoke
• Echocardiogram (ultrasound imaging of the heart)
• Anal opening very near the vagina opening in girls
• Fluids given through a vein (IV)
• Decreased visual acuity
• Swelling in scrotum
• Social

Less pain and improved walking ability or improvement on the Hospital for Special Surgery score were achieved in 75% of patients at 60 months and 60% of patients at 100 months [41] erectile dysfunction pills free trial viagra sublingual 100 mg order overnight delivery. A more recent metaanalysis included 46 studies of high tibial valgus osteotomy and consistently showed that after a 5- to 8-year follow-up erectile dysfunction medications drugs buy viagra sublingual 100 mg amex, 91 erectile dysfunction uk buy viagra sublingual australia. Many recommendations are based solely on expert opinion neurogenic erectile dysfunction causes viagra sublingual 100 mg purchase fast delivery, and therefore should be adjusted to each individual patient erectile dysfunction blog buy cheap viagra sublingual line. A six-month followup of a randomized trial comparing the efficacy of a lateral-wedge insole with subtalar strapping and an in-shoe lateral-wedge insole in patients with varus deformity osteoarthritis of the knee. A 2-year follow-up of a study to compare the efficacy of lateral wedged insoles with subtalar strapping and in-shoe lateral wedged insoles in patients with varus deformity osteoarthritis of the knee. Lateral wedge insoles for medial knee osteoarthritis: 12 month randomised controlled trial. Changes in knee adduction moment, pain, and functionality with a variablestiffness walking shoe after 6 months. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomized controlled study. Impact of cane use on pain, function, general health and energy expenditure during gait in patients with knee osteoarthritis: a randomised controlled trial. High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. The impact of a high tibial valgus osteotomy and unicondylar medial arthroplasty on the treatment for knee osteoarthritis: a meta-analysis. Efficacy of knee braces and foot orthoses in conservative management of knee osteoarthritis: a systematic review. Biomechanical effects of valgus knee bracing: a systematic review and meta-analysis. Patellofemoral joint osteoarthritis: an important subgroup of knee osteoarthritis. The additional effect of orthotic devices on exercise therapy for patients with patellofemoral pain syndrome: a systematic review. Patellar taping and bracing for the treatment of chronic knee pain: a systematic review and metaanalysis. Is there an evidence-based efficacy for the use of foot orthotics in knee and hip osteoarthritis Usefulness of an insole with subtalar strapping for analgesia in patients with medial compartment osteoarthritis of the knee. Effect of a novel insole on the subtalar joint of patients with medial compartment osteoarthritis of the knee. These presentations are dependent in part on psychological processes, including psychological distress, and specific personal and environmental factors. This chapter will first review studies on the prevalence of psychological distress, that is, depression, anxiety, and fatigue in osteoarthritis. Second, risk factors for an increase in pain and activity limitations will be reviewed. Specifically, the impact of psychological distress, personal factors, and environmental factors on pain and activity limitations will be addressed. A theoretical explanation about how psychological distress affects activity limitations. Note: the interventions are located close to the impairments and factors, which the interventions are targeting. Reprinted from Disability and Health, World Health Organization, International Classification of Functioning, Copyright (2001). Prevalence rates seem to depend on how depression is assessed, with lower rates in studies using a psychiatric interview or a physician diagnosis of depression (range 5. Impact of psychological risk factors on pain and activity limitations Psychological factors can negatively influence future pain and activity limitations. The literature is less consistent with regard to anxiety; two studies found an association [20, 22], while one study failed to find an association [8]. It should be noted, however, that only studies using a psychiatric interview or a physician diagnosis of anxiety disorder are available. Personal factors Personal factors include exercise, physical activity, coping strategies, and self-efficacy. Physical activity can vary from light-intensity to high-intensity/high-impact activities. In studies using questionnaires to record physical activity level, no association between physical activity and future activity limitations was found [19,23,28]; however, the validity of such questionnaires is questionable. High-impact physical activities, such as marathon running and occupational-related kneeling, may increase the risk of onset and progression of radiological progression [29], and may have a negative influence on physical functioning. In general, there is only weak or inconsistent evidence for coping strategies to predict future pain and activity limitations [13]. A specific pain coping strategy, however-avoidance of activity-seems to play a role in the course of activity limitations. In cross-sectional studies the relationship between avoidance of activities and activity limitations is firmly established [30]. Two other studies with a shorter follow-up period failed to find an association [23,33], possibly due to the short follow-up. Further information on the role of avoidance of activity is given in the next section. Self-efficacy is defined as the conviction that one can successfully execute the behaviour required to complete a task or activity [34]. Fatigue the prevalence rate of fatigue is less clear, primarily because of the lack of consensus on diagnostic criteria or cut off values. In a study using a visual analogue scale (scores ranging from 0 to 10; fatigue defined as a score of 2. Fatigue needs to be distinguished from depression, although unusual fatigue and a loss of energy are symptoms of depression. Some studies found less social support to be associated with future activity limitations [23,36], while other studies did not find an association [24,37]. Avoidance of activity the avoidance model aims to explain the impact of psychological distress. The model was introduced in 1992 [38], inspired by previous models in chronic pain, mainly low back pain [40,41]. This experience results in the expectation that renewed activity will again lead to pain. In the short term, avoidance of activity leads to less pain due to the decreased load on the symptomatic joint. However, in the long term, avoidance of activity results in physical deconditioning, most notably a decrease in muscle strength. All studies confirmed this hypothesis, including one longitudinal study [32] and two cross-sectional studies [43,44]. Further support for the relationships hypothesized in the avoidance model was found in cross-sectional and longitudinal studies [30]. In the 1-year long intervention, patients received improved depression care by a nurse or psychologist, working collaboratively with the patient and primary care physician. Treatment options included antidepressant medication, six to eight sessions of problem-solving therapy, and use of other mental health services. Compared to usual care, the intervention resulted in reduction of depressive symptoms, lower pain intensity, less interference with daily activities due to arthritis or pain, and improved general health. Although not designed to identify treatment mechanisms, the study shows that benefits of improved depression care extend beyond reduced depressive symptoms: improved depression care ameliorated pain and activity limitations. In a recent systematic review and metaanalysis, duloxetine was found to result in improved functioning, compared to placebo; however, the analysis suggested no difference in effect between duloxetine and non-steroidal anti-inflammatory drugs or opioids [45]. Pain coping skills training Pain coping skills training aims to teach cognitive and behavioural techniques which enable patients to reduce the impact of pain on functioning. Common techniques include relaxation, attention diversion, activity pacing, and reducing pain-related cognitions and emotions [46]. Interestingly, although the emphasis is on teaching techniques to deal with pain and although patients were not selected for symptoms of depression, pain coping skills training has been shown to also have an impact on depression, anxiety, and fatigue. No beneficial effects of self-management interventions were observed on self-management skills, pain, activity limitations (function), psychological distress, or quality of life, compared with an attention control intervention [55]. Compared with usual care, selfmanagement interventions may slightly improve self-management skills, pain, and activity limitations (function), although these benefits were rather small [55]. In order to improve outcome, it can be suggested to tailor specific components of self-management to the specific needs of patients. Behavioural strategies integrated into exercise therapy Exercise therapy consists of supervised strengthening, aerobic, flexibility and/or functional exercises. Since psychological factors have an impact on pain and activity limitations (see above), the integration of behavioural strategies into exercise therapy treatments seems a promising approach. The intervention is directed at increasing the level of activities in a time-contingent way, with the goal to integrate these activities in the daily living of patients. Time-contingency management means that the amount of activities/exercises is based on preset quotas and is not based on pain or other tolerance factors. Essential features of the operant conditioning approach are positive reinforcement of healthy behaviour, and withdrawal of attention toward pain behaviour. Both groups showed beneficial within-group effects on the outcome measures pain and activity limitations, both in the short and long term. It is based on the principles of cognitive behavioural therapy, which can be delivered to either groups or individually. By the end of the programme, participants are supposed to have learnt how to utilize physical activity to self-manage their symptoms. However, the added value of these interventions over exercise therapy alone, especially in the long term, is not firmly established yet and requires further study. However, a study comparing a partneroriented education and support intervention with a patientoriented intervention found less reduction of pain and activity limitations in the partner-oriented condition [59]. Improving exercise adherence Adherence to exercise is crucial for the effectiveness of exercise therapy. In a narrative review, Marks [61] identified desirable attributes of programmes to promote exercise adherence. He concluded that psychological interventions are an important attribute of programmes to promote exercise adherence. These authors concluded that therapeutic programmes that specifically address exercise adherence, selfmanagement programmes, and the graded activity programme (see also [63]) are effective in improving several aspects of exercise adherence. The delivery mode was found to affect adherence as well: supervised exercise, supplementing home exercises with group exercise, and refresher sessions promote adherence. Stronger input from evidence-based psychological theory into adherence programmes may lead to a significant advance in this field of research. Current approaches towards exercise adherence frequently lack a firm background in evidence-based psychological theory. Programmes to promote exercise adherence may be most efficient when tailored to the individuals mind set. They also need to develop an optimistic belief that they are capable of performing exercise (self-efficacy). Intenders, who are motivated to exercise but are not actually exercising, are supposed to benefit from interventions that help them to actually plan exercise and to plan strategies to cope with barriers and failures (planning). Actors, who are regularly doing exercise, may also benefit from interventions that bolster their beliefs in their capability to plan and maintain exercise and to recover from failure (self-efficacy). Marks [61] has listed desirable attributes of programmes to promote exercise adherence. Specifically, risk perception, planning, and tailoring of interventions to pre-intenders, intenders, and actors are not mentioned by Marks. It is suggested that effective adherence programmes need to incorporate these attributes. On the other hand, Marks points to skills acquisition: skilful instruction of exercise, modelling and shaping of exercise, and feedback on exercise performance are essential for the adoption and maintenance of exercise [67]. More generally, it is suggested that thoughtful integration of evidence-based psychological theory into research on exercise adherence programmes will significantly contribute to scientific progress in this field. In particular, catastrophic thoughts and exaggerated anxiety of pain play a pivotal role in the performance of daily physical activity [69,70]. Furthermore, psychological distress enhances the tendency to avoid activity in response to pain, resulting in deterioration of physical functioning [30]. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Prevalence and burden of osteoarthritis: results from a population survey in Norway. Identification of phenotypes with different clinical outcomes in knee osteoarthritis: data from the Osteoarthritis Initiative. Clinical phenotypes in patients with knee osteoarthritis: a study in the Amsterdam Osteoarthritis Cohort. Prognosis of pain and physical functioning in patients with knee osteoarthritis: systematic review and meta-analysis. Course and predictors of pain and physical functioning in patients with hip osteoarthritis: systematic review and meta-analysis. The influence of consulting primary care on knee pain in older people: a prospective cohort study. Predictors of onset and progression of knee pain in adults living in the community. Psychological health impact on 2-year changes in pain and function in persons with knee pain: data from the Osteoarthritis Initiative. When knee pain becomes severe: a nested casecontrol analysis in community-dwelling older adults. Knee confidence as it relates to physical function outcome in persons with or at high risk of knee osteoarthritis in the osteoarthritis initiative. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee 255 [71].

Viagra sublingual 100 mg with mastercard. Do You Need Penile Erection Enhancement Erectile Dysfunction And Penis Enlargement Treatment.

Certain drugs will increase synaptic activity by directly increasing the release of the neurotransmitter from the presynaptic terminal erectile dysfunction causes natural treatment purchase viagra sublingual 100 mg mastercard. Conversely erectile dysfunction viagra free trials buy viagra sublingual paypal, other compounds may inhibit the synapse by directly decreasing the amount of transmitter released during each action potential fluoride causes erectile dysfunction generic viagra sublingual 100 mg mastercard. An example is botulinum toxin (Botox) erectile dysfunction test video buy generic viagra sublingual 100 mg, which can be used as a skeletal muscle relaxant because of its ability to impair the release of acetylcholine from the skeletal neuromuscular junction (see Chapter 13) erectile dysfunction doctor in philadelphia 100 mg viagra sublingual order otc. After the neurotransmitter is released, some chemical synapses terminate activity primarily by transmitter reuptake. Reuptake involves the movement of the transmitter molecule back into the presynaptic terminal. A drug that impairs the reuptake of transmitter allows more of it to remain in the synaptic cleft and continue to exert an effect. For instance, tricyclic antidepressants (see Chapter 7) impair the reuptake mechanism that pumps amine neurotransmitters back into the presynaptic terminal, which allows the transmitter to continue to exert its effect and prolong activity at the synapse. Some synapses rely primarily on the enzymatic breakdown of the released transmitter to terminate synaptic activity. Inhibition of the enzyme responsible for terminating the transmitter allows more of the active transmitter to remain in the synaptic cleft, thereby increasing activity at the synapse. An example is using a drug that inhibits the cholinesterase enzyme as a method of treating myasthenia gravis. In myasthenia gravis, there is a functional decrease in activity at the skeletal neuromuscular junction. Anticholinesterase drugs such as neostigmine (Prostigmin) and pyridostigmine (Mestinon) inhibit acetylcholine breakdown, allowing more of the released neurotransmitter to continue to exert an effect at the neuromuscular synapse. As discussed in Chapter 4, chemical antagonists can block the postsynaptic receptor, thus decreasing synaptic transmission. These agents are antagonists that are specific for the beta-adrenergic receptors on the myocardium, and they are frequently used to treat hypertension, cardiac arrhythmias, and angina pectoris. Other drugs may improve synaptic transmission by affecting the receptor directly, so there is a tendency for increased neurotransmitter binding or improved receptor­effector coupling, or both. In addition to postsynaptic receptors, there are also receptors on the presynaptic terminal of some types of chemical synapses. These presynaptic receptors seem to serve as a method of negative feedback in controlling neurotransmitter release. Certain drugs may also be able to attenuate synaptic activity through presynaptic autoreceptors. However, the use of drugs that alter synaptic activity by binding to these autoreceptors is still somewhat new, and the full potential for this area of pharmacology remains to be determined. Drugs may alter synaptic transmission by affecting membrane organization and fluidity. Drugs that alter the fluidity of the presynaptic membrane could affect the way that presynaptic vesicles fuse with and release their neurotransmitter. Drug-induced changes in the postsynaptic membrane would affect the receptor environment and thereby alter receptor function. Membrane modification will result in either increased or decreased synaptic transmission, depending on the drug in question and the type and magnitude of membrane change. Alcohol (ethanol) and general anesthetics were originally thought to exert their effects by producing reversible changes in the fluidity and organization of the cell membranes of central neurons. Although this idea has been challenged somewhat, these drugs may still exert some of their effects via neuronal membranes. For example, the antihypertensive agent guanethidine (Ismelin) impairs both presynaptic storage and release of norepinephrine. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Novel and emerging strategies in drug delivery for overcoming the bloodbrain barrier. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Drugs affecting the brain and spinal cord usually exert their effects by somehow modifying synaptic transmission. Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease. Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Role of calcitonin gene-related peptide and substance P in different models of pain. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Nitric oxide signaling in the brain: translation of dynamics into respiration control and neurovascular coupling. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. At still higher doses, some sedative-hypnotics (especially barbiturates) will eventually bring on a state of general anesthesia. While producing sedation, many drugs will also decrease the level of anxiety in a patient. Of course, these anxiolytic properties often cause a decrease in the level of alertness in the individual. However, certain agents are available that can reduce anxiety without an overt sedative effect. Hence, these agents are classified as antianxiety drugs because they produce less sedation than their sedative-hypnotic counterparts. However, this distinction is relative because most antianxiety drugs produce some level of sedation, especially at higher doses. It is estimated that insomnia affects between 10 to 15 percent of the general population, and pharmacological management can be helpful in promoting normal sleep. As a rehabilitation specialist, you will encounter many physical therapy and occupational therapy patients who are taking sedative-hypnotic and antianxiety agents. It is important that you understand the basic pharmacology of these agents and their adverse effects. These agents are used to promote sleep, especially in relatively acute or short-term situations where sleep has been disturbed by illness, injury, or other factors. We will address the benzodiazepines first, followed by a description of the nonbenzodiazepine hypnotics. Benzodiazepines Benzodiazepines are a family of compounds that share the same basic chemical structure and pharmacological effects. Although the more famous members of this family are associated with treating anxiety. Virtually all benzodiazepines have sedative-hypnotic effects, and other benzodiazepines may be administered to produce sedation or sleep, depending on the dosage and the patient. Increased chloride conductance facilitates chloride entry into the neuron and results in hyperpolarization, or a decreased ability to raise the neuron to its firing threshold. Benzodiazepines seem to affect most or all of these subunits, hence their ability to produce sedative and antianxiety effects. But a drug that is selective for only the alpha-1 subunit might exert sedative effects without producing as many side effects. For instance, the discovery of opiate receptors initiated the search for endogenous opiate-like substances, which culminated in the discovery of the enkephalins. At higher doses, barbiturates also depress neuronal excitability in other areas of the brain and spinal cord. Nonbenzodiazepine Sedative-Hypnotics Pharmacologists have developed several drugs, including zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta) as sedative-hypnotics (see Table 6-1). Increased inhibition in certain areas of the brain results in less arousal and the promotion of sleep. The drugs also seem to have a lower risk of producing certain side effects and causing problems when discontinued (see "Problems and Adverse Effects," below). These drugs likewise tend to have a shorter duration of action than traditional benzodiazepines, thus decreasing the chance of residual or "hangover" effects the next day. Ramelteon (Rozerem) is another drug that can be used as an alternative to traditional sedative-hypnotic benzodiazepines. Melatonin, an endogenous neurohormone produced in the pineal gland, binds to melatonin receptors in the hypothalamus. Melatonin seems to be important in controlling sleep cycles and plays a key role in bringing about the onset of sleep. The potent sedative-hypnotic properties of these drugs have been recognized for some time, and their status as the premier medication used to promote sleep went unchallenged for many years. However, barbiturates are associated with a relatively small therapeutic index; approximately 10 times the therapeutic dose can often be fatal. These drugs are also very addictive, and their prolonged use often leads to drug abuse. Consequently, the lack of safety of the barbiturates and their strong potential for addiction and abuse necessitated the development of alternative nonbarbiturate drugs such as the benzodiazepines. Still, some barbiturates are occasionally used for their hypnotic properties; these drugs are listed in Table 6-1. Despite their extensive use in the past, the exact mechanism of the barbiturates remains somewhat unclear. This drug may also have a lower risk of side effects, including a reduced incidence of next day "hangover" symptoms and less tolerance and physical dependence during long-term use. Other Nonbenzodiazepines Practitioners can prescribe several other nonbenzodiazepine compounds for their sedative-hypnotic properties. Cyclic ethers and alcohols (including ethanol) can be included in this category, but their use specifically as sedative-hypnotics is fairly limited at present. The recreational use of ethanol in alcoholic beverages is an important topic in terms of abuse and long-term effects. However, since this area is much too extensive to be addressed here, only their sedative-hypnotic effect is considered. Lastly, practitioners can prescribe many other sedation-causing drugs to facilitate sleep in specific situations. For example, certain antihistamines (see Chapter 26) can cause profound sedation, and these drugs are often used in over-the-counter products that are promoted as "sleep aids. Sedation, however, is usually a side effect of these other medications, and these drugs are not typically advocated for treating classic insomnia or chronic sleep problems. Pharmacokinetics Benzodiazepine and nonbenzodiazepine sedativehypnotics are usually highly lipid soluble (Table 6-2). Sedativehypnotics are metabolized primarily by the oxidative enzymes of the drug-metabolizing system in liver cells. However, when the drugs slowly leak out of their peripheral storage sites, they can be redistributed to the brain and can cause low levels of sedation. This occurrence may help explain the "hangover" frequently reported the day after taking sedative-hypnotic drugs. Finally, excretion of these drugs occurs through the kidney after their metabolism in the liver. As with most drug biotransformations, metabolism of sedative-hypnotics is essential in creating a polar metabolite that is readily excreted by the kidney. Problems and Adverse Effects of Sedative-Hypnotics Residual Effects the primary problem associated with sedativehypnotic use is the residual effects that can occur the day after administration. Residual effects can result in serious or catastrophic problems when the patient must react quickly the next morning while driving a car, avoiding a fall, or performing other activities that require rapid motor responses. Although usually a minor problem, this can become serious if the drug-induced amnesia exacerbates an already existing memory problem, as might occur in some elderly patients. The residual problems can be resolved somewhat by taking a smaller dose or by using a drug with a shorter half-life (see Table 6-2). Nonetheless, residual effects may continue to be a problem even with these milder nonbenzodiazepine drugs, and patients should still be careful about driving and performing other activities that require quick responses until the effects of these drugs have worn off. Tolerance and Physical Dependence Another potential problem with long-term sedativehypnotic drug use is that prolonged administration may cause tolerance and physical dependence. Although these problems were originally thought to be limited to barbiturates, benzodiazepines and other sedative-hypnotics are now recognized as also causing tolerance and dependence when taken continually for several weeks. These complex behaviors seem to be most prevalent with some of the nonbenzodiazepine drugs, especially zolpidem (Ambien). Hence, patients taking these drugs should be monitored as closely as possible to ensure that they do not engage in such behaviors, and evidence of any strange activities should be brought to the attention of the physician immediately. Anxiety disorders can also be classified in several clinical categories, including generalized anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder, and posttraumatic stress syndrome. Many drugs-including sedative-hypnotics-have the ability to decrease anxiety levels, but this is usually at the expense of an increase in sedation. Frequently, alleviating anxiety without producing excessive sedation is desirable so that the individual can function at home, on the job, and so on. Consequently, certain drugs are available that have significant anxiolytic properties at doses that produce minimal sedation. We discuss benzodiazepine drugs and other nonbenzodiazepine strategies for dealing with anxiety below. Benzodiazepines As discussed previously, because of their relative safety, the benzodiazepines are often the primary drugs used to treat many forms of anxiety. The extensive use of this drug in treating nervousness and apprehension has made the trade name of this compound virtually synonymous with a decrease in tension and anxiety. Cardiovascular and respiratory depression may also occur, but these problems are dose-related and are usually not significant, except in cases of overdose. The antianxiety properties of benzodiazepines involve a mechanism similar or identical to their sedative-hypnotic effects.

Diseases

• Valproic acid antenatal infection
• Crow Fukase syndrome
• Diphtheria
• Navajo poikiloderma
• Encephalocele frontal
• Braddock Jones Superneau syndrome
• Deafness neurosensory pituitary dwarfism
• Davenport Donlan syndrome
• Stuart factor deficiency, congenital

References

• Snydman DR, Werner BG, Dougherty NN, et al. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. Transplant Proc. 1994;26:23-27.
• Bremner RM, Hoeft SF, Costantini M, et al: Pharyngeal swallowing: The major factor in clearance of esophageal reflux episodes. Ann Surg 218:364, 1993.
• Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998;98:2234-2251.
• Hoppin JA, Tolbert PE, Herrick RF, et al. Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30-60 years. Am J Epidemiol 1998;148(7):693-703.